Results 11 to 20 of about 642,073 (244)

Recurrent primary mucinous carcinoma of the skin

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2023
Primary cutaneous mucinous carcinoma of the skin is an adenocarcinoma of eccrine glands. However, it may be locally aggressive and can metastasize to lymph nodes.
Swagata Arvind Tambe, Priyanka Deelip Patil, Hemangi Jerajani   +2 more
doaj   +2 more sources

Primary cutaneous mucinous carcinoma: A rare entity

Indian Dermatology Online Journal, 2011
Primary mucinous carcinoma of the skin is a rare adnexal tumor of sweat gland origin. A case report is presented of a 70-year-old male, who presented with a slow growing mass near the lateral canthus of his left eye.
Kavita Mardi, Vijay Kumar Diwana
doaj   +2 more sources

Primary mucinous eccrine carcinoma of axillary skin: Report of a rare case

Indian Journal of Dermatopathology and Diagnostic Dermatology, 2017
Primary mucinous eccrine carcinoma is a rare low-grade malignancy of sweat gland. Axilla is an uncommon site of this tumor. Primary mucinous carcinoma mimics metastatic mucinous carcinoma from breast, gastrointestinal tract, lung, and ovary ...
Rajashree Pradhan, Subrata Pal, Palash Kr Mondal, Sajeeb Mondal   +3 more
doaj   +2 more sources

Gastric mucinous carcinoma with micropapillary carcinoma component: Case report of tumor morphology not previously described in stomach

Human Pathology: Case Reports, 2018
Micropapillary (MP) carcinoma is an uncommon tumor with a distinct histologic pattern. Although micropapillary carcinoma has been reported in the stomach, the concurrence of mucinous carcinoma and micropapillary carcinoma has not been reported to-date. A
Z.M. El-Zaatari, M.R. Schwartz, A.G. Ayala, J.Y. Ro   +3 more
doaj   +2 more sources

Mixed Mucinous Carcinoma of the Male Breast. [PDF]

Online Journal of Health & Allied Sciences, 2013
Male breast malignancy is extremely rare, representing less than 1% of all breast carcinomas. Infiltrating duct carcinoma is the commonest subtype.
Vandana Raphael, Hirakjyoti Das, Khonglah Yookarin, Rajni Sarma, Noor Topno   +4 more
doaj   +1 more source

Mucinous carcinoma of breast: Cytodiagnosis of a case

Journal of Cytology, 2011
Mucinous carcinoma of the breast is a relatively rare, pure form accounting for 2% of all breast cancers. Pure mucinous carcinoma of the breast has a favorable prognosis. The common age is postmenopausal group.
Sangeeta Sharma, Rani Bansal, Anjali Khare, Nivesh Agrawal   +3 more
doaj   +2 more sources

Role of multi-parametric MRI in the differentiation between mucinous breast carcinoma and fibroadenoma

The Egyptian Journal of Radiology and Nuclear Medicine, 2021
Background The purpose of this study was to evaluate diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and functional MRI (diffusion and MR spectroscopy) using the latest MRI breast imaging reporting and data system
Dalia Bayoumi, Amal Sakrana, Ebrahim Abdelhalim, Eman Alnaghy   +3 more
doaj   +1 more source

Mixed Mucinous Male Breast Carcinoma: A Rare Histological Variant of a Rare Disease [PDF]

Journal of Clinical and Diagnostic Research, 2018
Male breast carcinoma is rare neoplasm, accounting for
Badareesh Lakshminarayana, Ankita Harijee, Prashanth Shetty, Rama Rani Krishna Bhat   +3 more
doaj   +1 more source

Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC

Hepatology, EarlyView., 2022
Abstract Background and Aims Type 3 innate lymphoid cells (ILC3s) are essential for host defense against infection and tissue homeostasis. However, their role in the development of HCC has not been adequately confirmed. In this study, we investigated the immunomodulatory role of short‐chain fatty acids (SCFAs) derived from intestinal microbiota in ILC3
Chupeng Hu, Bingqing Xu, Xiaodong Wang, Wen‐Hua Wan, Jinying Lu, Deyuan Kong, Yu Jin, Wenhua You, Hua Sun, Xiaoxin Mu, Dongju Feng, Yun Chen   +11 more
wiley   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source